Clinical trial
A Phase 3, Randomized, Double-Blind, Dose-Ranging Evaluation of Transcutaneous Vagus Nerve Stimulation (tVNS) to Reduce Temper Outbursts in People With Prader-Willi Syndrome (PWS)
NCT06144645 is registered in ClinicalTrials.gov with Foundation for Prader-Willi Research as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 3, Randomized, Double-Blind, Dose-Ranging Evaluation of Transcutaneous Vagus Nerve Stimulation (tVNS) to Reduce Temper Outbursts in People With Prader-Willi Syndrome (PWS)
- Lead sponsor
- Foundation for Prader-Willi Research
- Phase
- Phase 3
- Overall status
- Active, not recruiting
- Start date
- January 8, 2024
- Completion date
- April 1, 2027
- Enrollment
- 102 (estimated)
- Sites
- 18
Conditions
As the registry lists them; a condition with its own page is linked.